Regenesis Biomedical’s CEO, Virginia Rybski, chats with the team at Beaker.com on her expereince at AdvaMed 2011 as well as shares a story of growth and progress.
Regenesis Biomedical, Inc. is a privately held medical technology company focused on developing and marketing noninvasive tissue regenerative medicine products. Regenesis developed, patented, and now markets the Provant® Therapy System.
Customers include health care facilities and providers that serve patients treated in acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home healthcare agencies, and outpatient clinics, as well as by patients in their homes by prescription.
Regenesis Biomedical, Inc. is a values-based company dedicated to our stakeholders: Patients, Clinicians, Shareholders, Suppliers and Employees.
Learn More at www.RegenesisBio.com